Patent intelligence · US
US 6783763
Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines
Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines
Patent details — US 6783763
- Jurisdiction
- US
- Status
- expired
- Grant date
- Aug 31, 2004
- Expiration
- Aug 26, 2024
- Applicant
- Peptide Immune Ligands
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K39/00, A61P
Quick answer
US 6783763 (Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines) is held by Peptide Immune Ligands. Status: expired. Granted Aug 31, 2004. Expires Aug 26, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Peptide Immune Ligands
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K39/00, A61P, A61P31/18, A61P37/02
More from Peptide Immune Ligands
Related pharmaceutical patents in our USPTO index.
-
US 12403087
Topical antiviral compositions, delivery systems, and methods of using the same
granted -
US 12319651
Crystalline forms and methods of producing crystalline forms of a compound
granted -
US 12246014
Azetidine derivatives
granted -
US 12208071
Glucagon receptor antagonists
granted -
US 12123012
Methods and compositions for nucleic acid and protein payload delivery
granted -
US 11970482
Acetal compounds and therapeutic uses thereof
granted -
US 11952364
TRK inhibitors useful as anticancer drugs
granted -
US 11773110
Heterocycle amines and uses thereof
granted
Frequently asked questions
What is US patent 6783763?
US 6783763 (Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines) is held by Peptide Immune Ligands. Status: expired. Granted Aug 31, 2004. Expires Aug 26, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6783763?
Peptide Immune Ligands is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 133 pharmaceutical patents for this assignee.
When does US 6783763 expire?
Our index shows an expiration date of Aug 26, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.